Gabriel Perez Baztarrica

Dr. Gabriel Perez Baztarrica


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2011 in Clinical Cardiology
Verified
Journal Article
Open access
PDF file
GBGabriel Perez Baztarrica
Gabriel Perez Baztarrica
LGLuis Gariglio
Luis Gariglio
FSFlavio Salvaggio
Flavio Salvaggio
EREstela Reolón
Estela Reolón
NBNorberto Blanco
Norberto Blanco
RPRafael Porcile
Rafael Porcile
Background: According to published evidence, treatment of infective endocarditis (IE) associated with cardiovascular implantable electronic devices (CIEDs) should include complete removal of the system. Several publications have shown that transvenous removal is an effective and safe nonthoracotomy approach in patients with large vegetations, but experiences with vegetations larger than 20 mm have rarely been reported.Hypothesis: Our aim was to describe our experience in percutaneous removal of CIEDs in patients with IE with large vegetations.Methods: The data were collected retrospectively and analyzed prospectively. We evaluated in‐hospital morbidity and mortality related to percutaneous removal of vegetations ≥20 mm. This included 8 cases with a follow‐up period of 20 months. We removed 100% of leads in the study population.Results: Two patients experienced minor complications. No patient experienced subclavian vein laceration, hemothorax and lead fracture, or severe tricuspid regurgitation. After the removal procedure, 2 patients had symptoms compatible with pulmonary embolism. Both in‐hospital mortality and mortality at follow‐up were zero.Conclusions: Transvenous extraction of pacing leads with larger vegetations is a feasible technique. There was a tendency toward symptomatic pulmonary embolism in patients with vegetations larger than 20 mm; however, morbidity and mortality were not influenced. We agree with the consensus that this procedure is highly useful and that the selection of the removal techniques will depend not only on the size of vegetation but also on prior cardiopulmonary conditions, concomitant cardiac surgery, atrial septal defect with risk of paradoxical embolism, center experience, and the possibility of complete removal of the device. © 2011 Wiley Periodicals, Inc.The authors have no funding, financial relationships, or conflicts of interest to disclose.

25 May 2010 in Circulation
Verified
Journal Article
Closed access
GBGabriel Perez Baztarrica
Gabriel Perez Baztarrica
NNNorma Nieva
Norma Nieva
LGLuis Gariglio
Luis Gariglio
FSFlavio Salvaggio
Flavio Salvaggio
RPRafael Porcile
Rafael Porcile

1 July 2013 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
GBGabriel Perez Baztarrica
Gabriel Perez Baztarrica
NBNorberto Bornancini
Norberto Bornancini
FSFlavio Salvaggio
Flavio Salvaggio
RPRafael Porcile
Rafael Porcile
Symptoms related to peripheral embolism are experienced in 2%-15% of cases of cardiac myxoma. We present a rare case of a 54-year-old man admitted due to sudden abdominal pain. A computed tomography (CT) scan showed occlusion of the superior mesenteric artery (SMA). As the patient's response to support treatment was favorable, a non-invasive approach was adopted, with prescription of oral anticoagulation (OAC) therapy. Transesophageal echocardiography revealed a tumor in the left atrium. The cardiac mass was completely removed and diagnosed as myxoma by histopathological analysis. As periodic CT scans showed progressive improvement of blood flow through the SMA, OAC was continued. OAC may have been beneficial due to the nature of emboli originating from a cardiac myxoma: thrombi covering the surface of the tumor. At present, there is no explanation in the literature for the benefits of OAC in patients with embolism associated with cardiac myxoma.

30 April 2009 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
GBGabriel Perez Baztarrica
Gabriel Perez Baztarrica
RCRoberto Cherjovsky
Roberto Cherjovsky
NBNorberto Blanco
Norberto Blanco
RPRafael Porcile
Rafael Porcile

1 January 2018 in Brazilian Journal of Cardiovascular Surgery
Verified
Journal Article
Open access
GBGabriel Perez Baztarrica
Gabriel Perez Baztarrica
GHGastón Heredia
Gastón Heredia
JAJuan Arellano
Juan Arellano
JFJuan Fernández
Juan Fernández
RPRafael Porcile
Rafael Porcile
A significant prosthetic paravalvular leak is an uncommon and severe postsurgical complication correlated to the occurrence of congestive heart failure and hemolytic anemia. Percutaneous treatment has become an attractive and effective proposal to relieve symptoms and reduce complications in patients whose high rate of morbidity/mortality precludes a new surgery. This is the case of an 81-year-old patient with a history of biological aortic valve replacement seeking medical help due to heart failure and hemolytic anemia, with a prosthetic paravalvular regurgitation jet and high surgical mortality according to EuroSCORE II.

14 September 2015 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
GBGabriel Perez Baztarrica
Gabriel Perez Baztarrica
MCMario L. Santa Cruz
Mario L. Santa Cruz
JAJuan P. Arellano
Juan P. Arellano
RPRafael Porcile
Rafael Porcile